Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 Against Crimean Congo Hemorrhagic Fever
Clinical trial NCT06684431 · COMPLETED
Trial details
- NCT number
- NCT06684431
- Sponsor
- Karolinska Institutet
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-12
- Primary completion
- 2026-03-17
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.